NO20032261D0 - Medisinske preparater - Google Patents

Medisinske preparater

Info

Publication number
NO20032261D0
NO20032261D0 NO20032261A NO20032261A NO20032261D0 NO 20032261 D0 NO20032261 D0 NO 20032261D0 NO 20032261 A NO20032261 A NO 20032261A NO 20032261 A NO20032261 A NO 20032261A NO 20032261 D0 NO20032261 D0 NO 20032261D0
Authority
NO
Norway
Prior art keywords
pharmacologically acceptable
pharmaceutical composition
esters
acceptable salts
medical preparations
Prior art date
Application number
NO20032261A
Other languages
English (en)
Other versions
NO20032261L (no
NO332938B1 (no
Inventor
Toshio Sada
Makoto Mizuno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26604360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032261(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20032261D0 publication Critical patent/NO20032261D0/no
Publication of NO20032261L publication Critical patent/NO20032261L/no
Publication of NO332938B1 publication Critical patent/NO332938B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
NO20032261A 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr NO332938B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000354327 2000-11-21
JP2001164009 2001-05-31
PCT/JP2001/010095 WO2002041890A1 (en) 2000-11-21 2001-11-19 Medicinal compositions

Publications (3)

Publication Number Publication Date
NO20032261D0 true NO20032261D0 (no) 2003-05-20
NO20032261L NO20032261L (no) 2003-07-09
NO332938B1 NO332938B1 (no) 2013-02-04

Family

ID=26604360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032261A NO332938B1 (no) 2000-11-21 2003-05-20 Farmasoytisk preparat som inneholder en spesifikk angiotensin II-reseptor-antagonist og hydroklortiazid, og anvendelsen derav for fremstilling av det farmasoytiske medikament for forebygging eller behandling av hypertensjon hos varmblodige dyr

Country Status (23)

Country Link
US (2) US6878703B2 (no)
EP (2) EP1595540A1 (no)
KR (1) KR100656716B1 (no)
CN (1) CN1265788C (no)
AT (1) ATE324890T1 (no)
AU (2) AU2002214324B2 (no)
BR (1) BR0115516A (no)
CA (1) CA2429260A1 (no)
CY (1) CY1106134T1 (no)
CZ (1) CZ20031367A3 (no)
DE (1) DE60119368T2 (no)
DK (1) DK1336407T3 (no)
ES (1) ES2262689T3 (no)
HU (1) HUP0400553A3 (no)
IL (2) IL155965A0 (no)
MX (1) MXPA03004463A (no)
NO (1) NO332938B1 (no)
NZ (1) NZ525913A (no)
PL (1) PL207252B1 (no)
PT (1) PT1336407E (no)
SK (1) SK5992003A3 (no)
TW (1) TWI262076B (no)
WO (1) WO2002041890A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3874419B2 (ja) * 2003-01-31 2007-01-31 三共株式会社 動脈硬化及び高血圧症の予防及び治療のための医薬
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
AU2004270161A1 (en) 2003-08-28 2005-03-17 Nicox S.A. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
WO2006029056A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
EP1855688A4 (en) 2005-02-24 2011-09-14 Nicox Sa NON-STAINED OXIDE DIURETIC COMPOUNDS, COMPOSITIONS AND USE PROCESSES
WO2006123766A1 (ja) * 2005-05-20 2006-11-23 Daichi Sankyo Company, Limited デキストロース含有フィルムコーティング製剤
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
WO2007047838A2 (en) * 2005-10-20 2007-04-26 Dr. Reddy's Laboratories Ltd. Process for preparing olmesartan medoxomil
US8077769B2 (en) * 2006-03-28 2011-12-13 Sony Corporation Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
SI1891952T1 (sl) * 2006-05-04 2012-02-29 Lek Pharmaceuticals, D.D. Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
WO2008054121A1 (en) * 2006-10-30 2008-05-08 Hanall Pharmaceutical Company. Ltd Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
ES2510866T3 (es) 2008-03-13 2014-10-21 Daiichi Sankyo Company, Limited Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
US20100008956A1 (en) * 2008-07-08 2010-01-14 Jie Du Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
CA3103599A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treatment of hypertension with an angiotensin ii receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3009911A (en) 1961-11-21 Derivatives of j
US2976289A (en) 1961-03-21 X-tetrahydro -
US2783241A (en) 1957-02-26 S-acylimino-x-substituted-az-i
US3025292A (en) 1962-03-13 Reduction of i
US3108097A (en) 1963-10-22 Ehnojs
US3254076A (en) 1966-05-31 Sulfamyl hydro
US2554816A (en) 1950-04-04 1951-05-29 American Cyanamid Co Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en) 1954-10-13 1958-05-21 Upjohn Co Heterocyclic sulphonamides
US2835702A (en) 1956-05-02 1958-05-20 Merck & Co Inc Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en) 1957-04-04 1961-04-18 Omikron Gagliardi Societa Di F Process for preparing heterocyclic sulfonamides
US3055904A (en) 1957-11-04 1962-09-25 Geigy Chem Corp New isoindoline derivatives
GB851287A (en) 1958-07-10 1960-10-12 British Drug Houses Ltd 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en) 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en) 1961-07-28 1965-01-06 May & Baker Ltd Isoindolinone derivatives
US3265573A (en) 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
NL299931A (no) 1962-10-30
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
US3163645A (en) 1964-09-25 1964-12-29 Ciba Geigy Corp Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (de) 1965-06-19 1968-06-20 Beiersdorf Ag 4-Chlor-5-sulfamylsalicylsaeure-(2', 6'-dimethyl)-anilid und dessen Alkali- oder Ammonium-Salze sowie Verfahren zu deren Herstellung
US3360518A (en) 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en) 1969-07-24 1972-01-11 Leo Pharm Prod Ltd Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (fr) 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0733366B1 (en) * 1988-01-07 1998-04-01 E.I. Du Pont De Nemours And Company Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310928A (en) 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist

Also Published As

Publication number Publication date
PL207252B1 (pl) 2010-11-30
EP1336407B1 (en) 2006-05-03
ATE324890T1 (de) 2006-06-15
CY1106134T1 (el) 2011-06-08
SK5992003A3 (en) 2003-11-04
HUP0400553A3 (en) 2010-03-29
CN1486182A (zh) 2004-03-31
DE60119368T2 (de) 2007-05-03
WO2002041890A1 (en) 2002-05-30
US20040002529A1 (en) 2004-01-01
DE60119368D1 (de) 2006-06-08
AU2002214324B2 (en) 2004-07-29
EP1336407A1 (en) 2003-08-20
CZ20031367A3 (cs) 2003-10-15
US6878703B2 (en) 2005-04-12
EP1336407A4 (en) 2004-07-14
NZ525913A (en) 2004-05-28
HK1054692A1 (en) 2003-12-12
HUP0400553A2 (hu) 2004-06-28
AU1432402A (en) 2002-06-03
DK1336407T3 (da) 2006-09-04
US20050113367A1 (en) 2005-05-26
BR0115516A (pt) 2004-02-03
CA2429260A1 (en) 2002-05-30
KR100656716B1 (ko) 2006-12-13
PL361093A1 (en) 2004-09-20
NO20032261L (no) 2003-07-09
ES2262689T3 (es) 2006-12-01
KR20030096235A (ko) 2003-12-24
EP1595540A1 (en) 2005-11-16
TWI262076B (en) 2006-09-21
PT1336407E (pt) 2006-07-31
CN1265788C (zh) 2006-07-26
IL155965A0 (en) 2003-12-23
IL155965A (en) 2008-08-07
MXPA03004463A (es) 2003-08-19
NO332938B1 (no) 2013-02-04

Similar Documents

Publication Publication Date Title
EP1336407A4 (en) MEDICAL COMPOSITIONS
EA200501075A1 (ru) Лекарственное средство для профилактики и лечения артериосклероза и гипертензии
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE475652T1 (de) Chinazolinderivate
BR0206955A (pt) Ligantes de receptores de canabinóides
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
DE69232022D1 (de) Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren
ATE297203T1 (de) Antithrombotische mitteln
PT1337535E (pt) Derivados de benzodiazepina
TR200202466T2 (tr) Felç, diyabet ve/veya konjesif kalp yetmezliğinin önlenmesinde kullanılan farmakolojik formülasyonlar.
DE60115465D1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
BR0214842A (pt) Inibidores de integrase hiv
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
WO2002026732A1 (en) Benzodiazepine derivative
TR199800165T1 (xx) (R)-5-bromo-n-(1-etil-4-metil hekzahidro-1h-1,4-diazepin-6-il)-2-metoksi-6- metilamino-3-piridinkarboksamid, bunu haz�rlamaya mahsus y�ntem ve bu bile�i�i ihtiva eden farmas�tik terkip.
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
EP1750703A4 (en) METHOD FOR REDUCING GASTROINTESTINAL TOXICITY BY ADMINISTRATION OF TEGAFUR
DE60034545D1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
ATE234098T1 (de) 4-aminopyrrole (3,2-d) pyrimidinen als antagonisten des neuropeptide y receptors
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
DE60022047D1 (de) Antivirale therapie
ATE270886T1 (de) Antivirale therapie

Legal Events

Date Code Title Description
MK1K Patent expired